The company’s Q4 top and bottom line figures represent a massive increase of 265% and 765% over last year’s fourth…
Read More »
Last Updated: [wpdts-custom start=”post-modified” format=”j.n.Y G:i”] Who were the winners and losers of last week’s big tech earnings season? Let’s…
Read More »
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, is pleased to announce that the United States…
Read More »
With Trump winning decisively again tonight in New Hampshire by double digits, investors should keep an eye on these two…
Read More »
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced certain preliminary, unaudited management-prepared financial results for…
Read More »
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce it has signed an…
Read More »
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announces participation in three aesthetic industry conferences in…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a medical aesthetic company specializing in physician-dispensed skincare, today reported its fiscal 2023 Q3 financial results.…
Read More »
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce its new partnership with…
Read More »
Last Updated: [wpdts-custom start=”post-modified” format=”j.n.Y G:i”] The data in the new JOLTS Report should be music to the Fed’s ears,…
Read More »